PARAZAN

PARAZAN

  • Praziquantel 50 mg – Fenbendazol 500 mg
  • Tablets, divisible into 4
  • Boxes with 2, 6 and 100 tablets
Cats
Dogs

Package leaflet for

PARAZAN, tablets

NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT

Marketing authorisation holder:

Prodivet pharmaceuticals sa/nv
Hagbenden 39c
B-4731 EYNATTEN

Manufacturer responsible for the batch release:

LABORATORIA WOLFS NV
Westpoort, 50
B – 2070 ZWIJNDRECHT

NAME OF THE VETERINARY MEDICINAL PRODUCT

PARAZAN, tablets
Praziquantel 50,0 mg - Fenbendazole 500,0 mg

STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)

Active substances: Praziquantel 50,0 mg - Fenbendazole 500,0 mg
Excipients: Carmellosum natricum conexum - Natrii laurilsulfas - Polyvidonum - Magnesii stearas q.s. pro tabletta compr. una.
Round cross-scored tablets bi-convex, white.

INDICATION(S)

Anthelmintic
Treatment of mixed parasitic infections due to adult nematodes (round worms) and cestodes (tapeworms) in all breeds of dogs and cats.

In the dog:

Nematodes: Ancylostoma caninum, Toxocara canis, Toxascaris leonina, Trichuris vulpis, Uncinaria stenocephala
Cestodes: Dipylidium caninum, Echinococcus granulosus, Taenia spp, Echinococcus multilocularis, Mesocestoïdes spp.

In the cat:

Nematodes: Ancylostoma tubaeforme, Toxascaris leonida, Toxacara cati
Cestode: Dipylidium caninum, Echinococcus multilocularis, Taenia taeniaformis

CONTRAINDICATIONS

None

ADVERSE REACTIONS

Slight vomiting and diarrhea can occur occasionally at high dosages, especially in cats.
If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.

TARGET SPECIES

Dogs and cats

DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION

Oral route
The recommended dosage is 5 mg Praziquantel and 50 mg Fenbendazole per kg body weight, which corresponds to 1 tablet per 10 kg body weight. The administration should be repeated the day after.
In case of infestation by Ancylostoma caninum, Uncinaria stenocephala, Trichuris vulpis, Echinococcus granulosus, administer one tablet per 10 kg body weight during 3 consecutive days.  The dosage for cats dependent of their weight is generally ½ tablet per cat.

ADVICE ON CORRECT ADMINISTRATION

The administration of the tablets is performed directly, with or without food. No dietetic measure or fasting is necessary.

WITHDRAWAL PERIOD

Not necessary

SPECIAL STORAGE PRECAUTIONS

Keep out of the sight and reach of children.
This veterinary medicinal product does not require any special storage conditions
Do not use this veterinary medicinal product after the expiry date which is stated on the package

SPECIAL WARNING(S)

Particular warnings for use in animal

Pregnancy

The safety of the veterinary medicinal product has not been established during pregnancy.
The use is not recommended in case of gravidity.

Lactation

The treatment of puppies en kittens should start in the third week of age, after a diagnostic of mixed infection.

Interaction with other medicinal products and other forms of interaction

Do not administer with other anthelmintics

Overdose (symptoms, emergency measures, antidotes)

After an overdose of 5 times the recommended dose, vomiting and diarrhea can occur.

Special precautions to be taken by the person administering the veterinary medicinal product to the animals

None

SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE
MATERIAL, IF ANY

Medicines should not be disposed of via wastewater or household waste
Ask your veterinary surgeon how to dispose of medicines no longer required. These measures should help to protect the environment.

DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED

May 2017

OTHER INFORMATION

Oral Tablets for veterinary use, packs of 2, 6, 10, 20, 50, 100 tablets under blister. Not all pack sizes may be marketed.
 
BE-V199421
 
Free delivery.
 
For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
 

MARKETING AUTHORIZATION HOLDER:

PRODIVET Pharmaceuticals S.A./N.V.
Hagbenden 39c
B - 4731 EYNATTEN
Phone : 00 32 (0)87 85 20 25
Fax : 00 32 (0)87 86 68 20
e-mail :info@prodivet.com
 
 
Parazan-not-GB- V7-20170529